UNSPSC 51422356: Methylprednisolone sodium succinate

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H33O8.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LEC9GKY20K, chemically known as 1,4-butanedioic acid (succinic acid) but more generally known as methylprednisolone sodium succinate, which bears US NIH Compound Identifier 1110. European Medicines Agency schedules Methylprednisolone sodium succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14562MIG.

UNSPSC 51422356 Methylprednisolone sodium succinate is a Commodity code for a corticosteroid pharmaceutical product, but the single recent state and local opportunity posted under it—Seminole County, Florida IFB 60459723LAS—does not involve this medication. Instead, Seminole County sought to procure naloxone and safe drug deactivation systems through competitive bidding, a pharmaceutical-adjacent purchase disconnected from the code's stated scope. The mismatch suggests either a data-entry error in the opportunity classification or inconsistent UNSPSC assignment at the issuing level. State and local governments use methylprednisolone sodium succinate and similar corticosteroids primarily for emergency medical response, public health departments' stock supplies, and hospital and clinic operations within health agencies and school districts, though recent activity under this specific code is not evident.

The single identifiable recent opportunity originates from Seminole County, Florida, an IFB released June 30, 2026 (due July 26, 2023, a backdated deadline likely reflecting a historical posting date). Seminole County's naloxone procurement required 1,900 units annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, along with 800 safe drug deactivation systems, under a two-year initial term with optional one-year renewal. The solicitation imposed standard state and local compliance requirements including drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and potential FEMA-funded compliance obligations. The code shows minimal recent activity in state and local procurement; pursue only if your firm carries this specific corticosteroid formulation and targets health departments and emergency services providers directly rather than relying on UNSPSC-based opportunity feeds.